AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.6 Out of 5 (5234 Reviews)

KSquare made mutual fund investing enjoyable. I track everything on one dashboard and have learned a lot through their educational resources. Perfect for professionals.

Sakshi Talreja

Sakshi Talreja

Psychotherapist

I've explored several NFOs through KSquare, and their consistent communication builds trust. It’s great having expert updates every step of the way.

Kunal Deshpande

Kunal Deshpande

Media Producer

The NFO section on KSquare is so well designed. I love the simplified jargon and timely alerts before each launch. Great for busy professionals!

Prachi Wadhwa

Prachi Wadhwa

Veterinarian

KSquare helped me understand what to expect from each NFO. Their breakdown of fund strategy and goals made my investment decision very easy.

Yuvraj Sinha

Yuvraj Sinha

Chemical Analyst

I use KSquare to manage my NRI investments. They provide clarity, legal compliance, and reliable support every step of the way. Excellent platform!

Siddharth Jain

Siddharth Jain

Business Owner

I used to avoid NFOs due to uncertainty. KSquare’s clear data and investor tools changed my mind. Now, I feel fully informed and prepared.

Ankita Pillai

Ankita Pillai

Tour Operator

KSquare simplified wealth creation for me. Instead of random investments, I now follow a clear long-term strategy that actually grows. Their disciplined guidance gives consistent financial confidence every month.

Rhea Fernandes

Rhea Fernandes

Getting a loan against my mutual funds was hassle-free with KSquare. Very professional and transparent experience.

Rohit Verma

Rohit Verma

Marketing Consultant

I’m impressed by how easy KSquare made mutual fund investing. Their platform is clean, quick, and their support staff is always ready to help.

Reena Saxena

Reena Saxena

Art Teacher

Being self-employed, I wanted a structured way to invest. KSquare’s SIPs fit the bill. It’s affordable, effective, and easy to track progress over time.

Kritika Jain

Kritika Jain

Event Planner

FAQ's

Frequenlty Asked Question

How do I track mutual fund performance on KSquare?

KSquare offers a dashboard where you can view real-time NAV, portfolio value, returns, and performance trends.

Can I set up automatic investments through KSquare?

Yes, KSquare allows SIP setup, automating monthly investments to help build disciplined saving habits.

Is SIP a good option for first-time investors?

Absolutely! SIPs are ideal for beginners due to their simplicity, flexibility, and potential for long-term wealth creation.

Does KSquare provide research reports on NFOs?

Yes, KSquare offers fund highlights, investment strategy, and expert opinions to help you evaluate each NFO thoroughly.

How are NFO units allotted after subscription closes?

After the subscription period, units are allotted based on the face value and investment amount on the allotment date.

Can NRIs invest in mutual funds through KSquare?

Yes, NRIs can easily invest in SEBI-registered mutual funds via KSquare using NRE or NRO bank accounts.

Is there a lock-in period for mutual fund investments?

Only ELSS funds have a 3-year lock-in. Other funds generally allow you to redeem anytime based on NAV.

Can NRIs get a loan against mutual funds with KSquare?

Some lenders allow NRIs to avail loans. KSquare helps identify NRI-eligible lenders and assists with documentation.

App Store